2Wk·

Iradimed Q3/26 Earnings

A niche player $IRMD (-1.34%) in the healthcare sector; strong quarter, but management has slightly lowered its guidance. If the stock price drops a bit more, the valuation could become attractive again...

attachment
3
2 Comments

profile image
Definitely an underrated player 👍
•
2
•
profile image
@Aktienhauptmeister It certainly looks interesting, especially since they operate debt-free. But the valuation is still quite high.
••
Join the conversation